About BBOT
BBOT is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies. BBOT has the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors. For more information visit BBOTx.com
Position Summary
The Quality team is seeking an experienced, detail-oriented, and highly motivated Quality Affairs Consultant with deep Good Clinical Practice (GCP) expertise to support BBOT’s clinical-stage oncology programs. This is a remote, hourly contract engagement in which the consultant will provide independent GCP quality oversight across BBOT’s clinical trials, Contract Research Organizations (CROs), clinical vendors, and investigator sites. The consultant will partner closely with Clinical Operations, Clinical Development, Regulatory Affairs, Biometrics, and Drug Safety, and will report to the [Head of Quality]. The ideal candidate will bring hands-on GCP auditing and inspection-readiness experience, sound risk-based judgment, and the ability to work independently and deliver results in a dynamic, fast-paced biotech environment.
Key Responsibilities
· Provide GCP quality oversight for BBOT’s Phase 1–3 oncology clinical trials, ensuring compliance with ICH E6(R3), FDA regulations (21 CFR Parts 11, 50, 54, 56, and 312), and applicable global requirements
· Plan, conduct, and report risk-based GCP audits of investigator sites, CROs, central and specialty laboratories, and other clinical vendors, and track findings through corrective and preventive action (CAPA) closure
· Support vendor qualification and ongoing oversight, including review of quality agreements, CRO quality and oversight plans, and maintenance of a risk-based clinical audit schedule
· Lead or support inspection-readiness activities for regulatory agency inspections (e.g., FDA BIMO), including mock inspections, storyboard development, and front-room and back-room support during inspections
· Perform Trial Master File (TMF) quality reviews to assess completeness, timeliness, and quality against study TMF plans and the TMF Reference Model
· Assess and triage quality events, significant protocol deviations, and potential serious breaches; partner with cross-functional teams on root cause analysis and effective CAPA development
· Review key clinical study documents (e.g., protocols, informed consent forms, monitoring plans, data management plans, and safety management plans) for GCP compliance and quality risk
· Contribute to risk-based quality management (RBQM) in alignment with ICH E6(R3), including identification of critical-to-quality factors and quality tolerance limits
· Support the development and continuous improvement of GCP-related SOPs, work instructions, and the clinical quality management system using a phase-appropriate approach
· Serve as a GCP subject-matter expert, delivering training and providing day-to-day guidance to Clinical Operations and other study team members
· Prepare clinical quality metrics and status reports for Quality and Clinical leadership, escalating significant compliance risks in a timely manner
· Support computerized system assessments for clinical systems (e.g., EDC, eTMF, IRT, ePRO) with respect to 21 CFR Part 11 and data integrity expectations, as needed
Qualifications
· Bachelor’s degree in life sciences, nursing, pharmacy, or a related field; advanced degree and/or relevant certification (e.g., RQAP-GCP, ASQ CQA) preferred
· 10+ years of GCP quality assurance experience in biotech, pharma, or CRO settings, including at least 5 years independently conducting GCP audits; oncology experience strongly preferred
· Expert working knowledge of ICH E6(R3), FDA GCP regulations, and EU Clinical Trials Regulation (EU 536/2014), with familiarity with other global GCP requirements
· Direct experience preparing for, hosting, or supporting FDA and/or EMA GCP inspections
· Demonstrated experience auditing CROs and investigator sites, writing clear and well-supported audit reports, and driving CAPA to effective closure
· Experience working with eTMF, EDC, and electronic quality management systems (e.g., Veeva Vault) is a plus
· Demonstrated ability to operate independently as a senior consultant, setting priorities across multiple studies and driving work to completion with minimal oversight
· Pragmatic, risk-based, and phase-appropriate approach to quality, with experience supporting small- to mid-size biotech companies preferred
· Track record of collaboration and influencing cross-functional stakeholders and external partners without formal authority
· Strong written and oral communication skills, with the ability to present complex compliance concepts in a clear and actionable manner
· Availability to commit an estimated 25-29 hours per week, with flexibility to scale during inspections or peak study activity, and ability to travel occasionally for audits (up to 10%)
Compensation and Engagement Details
This is a remote, hourly contract engagement. The anticipated duration is 6 months, with the possibility of extension based on business needs, at an estimated 25-29 hours per week. Candidates must be based in the United States and able to collaborate across U.S. time zones.
The anticipated hourly rate for this engagement is $60 – $100 per hour. The final rate will depend on the candidate’s experience, expertise, and qualifications.
As a contract (non-employee) engagement, this position is not eligible for BBOT employee benefits, bonus, or equity programs. Engagement terms, including scope of work and deliverables, will be defined in a consulting or statement of work agreement directly with BBOT / through a third-party staffing partner.